Syros Pharmaceuticals SYRS

$ 0.27 -8.0%

Quarterly report 2024-Q3
added 10-31-2024

Syros Pharmaceuticals Balance Sheet 2011-2024 | SYRS

Annual Balance Sheet Syros Pharmaceuticals

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-103 M	-125 M	-50.3 M	-133 M	-15.5 M	-49.9 M	-32.2 M	-58.4 M	-35.6 M	-60.4 M	-	-	-
Long Term Debt	34.6 M	40.6 M	40.3 M	39.6 M	-	-	-	-	-	-	-	-	-
Long Term Debt Current	2.32 M	2.01 M	1.72 M	1.46 M	1.04 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	47.3 M	8.65 M	751 K	1.15 M	1.63 M	1 K	-	-	-
Total Current Liabilities	36.7 M	30.8 M	31.5 M	28.6 M	23.5 M	19.5 M	12.4 M	9.57 M	-	-	-	-	-
Total Liabilities	-	-	-	-	70.8 M	28.2 M	13.2 M	10.7 M	9.58 M	1.25 M	-	-	-
Deferred Revenue	-	4.33 M	10.2 M	12.2 M	5.74 M	1.93 M	-	550 K	-	-	-	-	-
Retained Earnings	-723 M	-558 M	-464 M	-377 M	-293 M	-218 M	-155 M	-101 M	-53.5 M	-23.7 M	-	-	-
Total Assets	168 M	244 M	183 M	213 M	150 M	107 M	78.5 M	91.3 M	43.6 M	61.5 M	-	-	-
Cash and Cash Equivalents	140 M	167 M	92.3 M	174 M	41.4 M	49.9 M	32.2 M	58.6 M	35.9 M	60.4 M	-	-	-
Book Value	168 M	244 M	183 M	213 M	79.2 M	78.6 M	65.3 M	80.6 M	34 M	60.2 M	-	-	-
Total Shareholders Equity	16.7 M	128 M	85.2 M	90.6 M	79.2 M	78.6 M	65.3 M	80.6 M	-48 M	-21.8 M	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Syros Pharmaceuticals

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	41.1 M	40.9 M	29.7 M	34.6 M	39.4 M	40.9 M	39.1 M	40.6 M	40.5 M	34 M	38.8 M	40.3 M	40.1 M	39.9 M	39.7 M	39.6 M	39.6 M	39.6 M	39.6 M	621 K	621 K	621 K	621 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	139 K	2.18 M	3.24 M	4.33 M	1.62 M	3.59 M	7.77 M	10.2 M	12 M	12.1 M	12.8 M	12.2 M	12.2 M	12.2 M	12.2 M	5.74 M	5.74 M	5.74 M	5.74 M	1.93 M	1.93 M	1.93 M	1.93 M	-	-	-	-	550 K	550 K	550 K	550 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-756 M	-750 M	-727 M	-723 M	-658 M	-618 M	-582 M	-558 M	-553 M	-523 M	-489 M	-464 M	-440 M	-414 M	-391 M	-377 M	-377 M	-377 M	-377 M	-293 M	-293 M	-293 M	-293 M	-218 M	-218 M	-218 M	-218 M	-155 M	-155 M	-155 M	-155 M	-101 M	-101 M	-101 M	-101 M	-53.5 M	-53.5 M	-53.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	85 M	107 M	135 M	168 M	148 M	181 M	205 M	244 M	285 M	126 M	152 M	183 M	208 M	234 M	261 M	213 M	213 M	213 M	213 M	150 M	150 M	150 M	150 M	107 M	107 M	107 M	107 M	78.5 M	78.5 M	78.5 M	78.5 M	91.3 M	91.3 M	91.3 M	91.3 M	43.6 M	43.6 M	43.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	58.3 M	79 M	83.5 M	140 M	112 M	115 M	105 M	167 M	172 M	59.1 M	69.6 M	92.3 M	119 M	164 M	222 M	177 M	174 M	174 M	174 M	41.4 M	41.4 M	41.4 M	41.4 M	49.9 M	49.9 M	49.9 M	49.9 M	32.2 M	32.2 M	32.2 M	32.2 M	58.6 M	58.6 M	58.6 M	58.6 M	35.9 M	35.9 M	35.9 M	-	60.4 M	-	-	-	3.8 M	-	-	-	-	-	-	-	-	-	-	-
Book Value	85 M	107 M	135 M	168 M	148 M	181 M	205 M	244 M	285 M	126 M	152 M	183 M	208 M	234 M	261 M	213 M	213 M	213 M	213 M	150 M	150 M	150 M	150 M	107 M	107 M	107 M	107 M	78.5 M	78.5 M	78.5 M	78.5 M	91.3 M	91.3 M	91.3 M	91.3 M	43.6 M	43.6 M	43.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-11.1 M	-6.35 M	15.1 M	16.7 M	36.3 M	73.2 M	107 M	128 M	129 M	31 M	62.7 M	85.2 M	106 M	130 M	150 M	90.6 M	90.6 M	90.6 M	90.6 M	79.2 M	79.2 M	79.2 M	79.2 M	78.6 M	78.6 M	78.6 M	78.6 M	65.3 M	65.3 M	65.3 M	65.3 M	80.6 M	80.6 M	80.6 M	80.6 M	-48 M	-48 M	-48 M	-	-21.8 M	-	-	-	-9.29 M	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency